Advertisement
Screener

SCYNEXIS, Inc. (SCYX) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

SCYNEXIS, Inc. Preferred Stock, Shares Authorized

SCYNEXIS, Inc. (SCYX) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-10

  • 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-305.00M shares
10-Q · filed 2026-08-10
2026-03-315.00M shares
10-Q · filed 2026-05-11
2025-12-315.00M shares
10-Q · filed 2026-08-10
2025-09-305.00M shares
10-Q · filed 2025-11-05
2025-06-305.00M shares
10-Q · filed 2025-08-13
2025-03-315.00M shares
10-Q · filed 2025-05-15
2024-12-315.00M shares
10-K · filed 2026-03-04
2024-09-305.00M shares
10-Q · filed 2024-11-06
2024-06-305.00M shares
10-Q · filed 2024-08-08
2024-03-315.00M shares
10-Q · filed 2024-05-08
2023-12-315.00M shares
10-K · filed 2025-03-12
2023-09-305.00M shares
10-Q · filed 2023-11-13
2023-06-305.00M shares
10-Q · filed 2023-08-14
2023-03-315.00M shares
10-Q · filed 2023-05-10
2022-12-315.00M shares
10-K · filed 2024-03-28
2022-09-305.00M shares
10-Q · filed 2022-11-09
2022-06-305.00M shares
10-Q · filed 2022-08-15
2022-03-315.00M shares
10-Q · filed 2022-05-12
2021-12-315.00M shares
10-K · filed 2023-03-31
2021-09-305.00M shares
10-Q · filed 2021-11-10
2021-06-305.00M shares
10-Q · filed 2021-08-16
2021-03-315.00M shares
10-Q · filed 2021-05-17
2020-12-315.00M shares
10-K · filed 2022-03-29
2020-09-305.00M shares
10-Q · filed 2020-11-06
2020-06-305.00M shares
10-Q · filed 2020-08-10
2020-03-315.00M shares
10-Q · filed 2020-05-11
2019-12-315.00M shares
10-K · filed 2021-03-29
2019-09-305.00M shares
10-Q · filed 2019-11-12
2019-06-305.00M shares
10-Q · filed 2019-08-07
2019-03-315.00M shares
10-Q · filed 2019-05-08
2018-12-315.00M shares
10-K · filed 2020-03-11
2018-09-305.00M shares
10-Q · filed 2018-11-13
2018-06-305.00M shares
10-Q · filed 2018-08-09
2018-03-315.00M shares
10-Q · filed 2018-05-08
2017-12-315.00M shares
10-K · filed 2019-03-14
2017-09-305.00M shares
10-Q · filed 2017-11-07
2017-06-305.00M shares
10-Q · filed 2017-08-08
2017-05-075.00M shares
10-K · filed 2018-03-13
2017-03-315.00M shares
10-Q · filed 2017-05-08
2016-12-315.00M shares
10-K · filed 2018-03-13
2016-09-305.00M shares
10-Q · filed 2016-11-07
2016-06-305.00M shares
10-Q · filed 2016-08-08
2016-03-315.00M shares
10-Q · filed 2016-05-09
2015-12-315.00M shares
10-K · filed 2017-03-13
2014-12-315.00M shares
10-K · filed 2016-03-07
2014-05-075.00M shares
10-K · filed 2026-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98